In November 2017 $ETST initiated audit process to up-list to the OTCQB market and began a pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula is based on industrial hemp CBD oil mixed with a known natural ingredient proven to help increase dopamine levels. The formula is expected to decrease cravings and the alleviate negative effects of withdrawals in addicts.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!